Susquehanna International Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $144M | Buy |
1,032,658
+446,635
| +76% | +$62.5M | 0.02% | 642 |
|
|
2025
Q4 | $71.9M | Buy |
586,023
+166,717
| +40% | +$20.3M | 0.01% | 1087 |
|
|
2025
Q3 | $46.5M | Buy |
419,306
+20,194
| +5% | +$2.3M | 0.01% | 1399 |
|
|
2025
Q2 | $44.2M | Buy |
399,112
+238,646
| +149% | +$25.4M | 0.01% | 1248 |
|
|
2025
Q1 | $18M | Sell |
160,466
-441,080
| -73% | -$45.5M | ﹤0.01% | 1843 |
|
|
2024
Q4 | $55.6M | Buy |
601,546
+315,347
| +110% | +$28.4M | 0.01% | 1035 |
|
|
2024
Q3 | $24M | Sell |
286,199
-131,217
| -31% | -$10M | ﹤0.01% | 1640 |
|
|
2024
Q2 | $28.6M | Buy |
417,416
+40,826
| +11% | +$2.72M | 0.01% | 1401 |
|
|
2024
Q1 | $27.6M | Sell |
376,590
-195,565
| -34% | -$15M | ﹤0.01% | 1486 |
|
|
2023
Q4 | $46.4M | Buy |
572,155
+94,038
| +20% | +$7.32M | 0.01% | 1089 |
|
|
2023
Q3 | $35.8M | Sell |
478,117
-222,857
| -32% | -$17.1M | 0.01% | 1247 |
|
|
2023
Q2 | $54M | Sell |
700,974
-267,683
| -28% | -$21.3M | 0.01% | 937 |
|
|
2023
Q1 | $80.4M | Buy |
968,657
+234,360
| +32% | +$19.4M | 0.02% | 686 |
|
|
2022
Q4 | $63M | Sell |
734,297
-25,466
| -3% | -$2.02M | 0.02% | 760 |
|
|
2022
Q3 | $46.9M | Buy |
759,763
+208,000
| +38% | +$13.1M | 0.01% | 835 |
|
|
2022
Q2 | $34.1M | Sell |
551,763
-1,084,222
| -66% | -$67.1M | 0.01% | 1061 |
|
|
2022
Q1 | $97.3M | Buy |
1,635,985
+1,156,450
| +241% | +$73.9M | 0.02% | 669 |
|
|
2021
Q4 | $34.8M | Sell |
479,535
-3,524,168
| -88% | -$243M | 0.01% | 1368 |
|
|
2021
Q3 | $280M | Buy |
4,003,703
+522,678
| +15% | +$36.7M | 0.04% | 397 |
|
|
2021
Q2 | $240M | Buy |
3,481,025
+284,753
| +9% | +$19M | 0.03% | 432 |
|
|
2021
Q1 | $207M | Sell |
3,196,272
-5,510,839
| -63% | -$355M | 0.03% | 435 |
|
|
2020
Q4 | $507M | Buy |
8,707,111
+2,577,017
| +42% | +$155M | 0.08% | 185 |
|
|
2020
Q3 | $387M | Buy |
6,130,094
+2,480,735
| +68% | +$172M | 0.07% | 191 |
|
|
2020
Q2 | $281M | Sell |
3,649,359
-951,933
| -21% | -$73M | 0.07% | 229 |
|
|
2020
Q1 | $344M | Sell |
4,601,292
-520,427
| -10% | -$36M | 0.11% | 145 |
|
|
2019
Q4 | $333M | Buy |
5,121,719
+815,664
| +19% | +$53.1M | 0.1% | 169 |
|
|
2019
Q3 | $273M | Buy |
4,306,055
+129,652
| +3% | +$8.48M | 0.09% | 178 |
|
|
2019
Q2 | $282M | Buy |
4,176,403
+184,723
| +5% | +$12.2M | 0.1% | 159 |
|
|
2019
Q1 | $260M | Sell |
3,991,680
-779,834
| -16% | -$51.8M | 0.11% | 151 |
|
|
2018
Q4 | $298M | Buy |
4,771,514
+525,858
| +12% | +$36.8M | 0.12% | 139 |
|
|
2018
Q3 | $328M | Sell |
4,245,656
-1,949,743
| -31% | -$147M | 0.11% | 146 |
|
|
2018
Q2 | $439M | Buy |
6,195,399
+1,713,539
| +38% | +$121M | 0.15% | 97 |
|
|
2018
Q1 | $338M | Sell |
4,481,860
-1,901,750
| -30% | -$151M | 0.12% | 128 |
|
|
2017
Q4 | $457M | Buy |
6,383,610
+940,945
| +17% | +$71.5M | 0.16% | 86 |
|
|
2017
Q3 | $441M | Sell |
5,442,665
-4,690,264
| -46% | -$359M | 0.17% | 89 |
|
|
2017
Q2 | $717M | Sell |
10,132,929
-640,022
| -6% | -$42.6M | 0.32% | 43 |
|
|
2017
Q1 | $732M | Buy |
10,772,951
+2,537,841
| +31% | +$178M | 0.37% | 36 |
|
|
2016
Q4 | $590M | Sell |
8,235,110
-481,784
| -6% | -$35.8M | 0.3% | 47 |
|
|
2016
Q3 | $690M | Buy |
8,716,894
+4,665,666
| +115% | +$379M | 0.33% | 42 |
|
|
2016
Q2 | $338M | Buy |
4,051,228
+1,691,816
| +72% | +$150M | 0.18% | 90 |
|
|
2016
Q1 | $217M | Buy |
2,359,412
+118,015
| +5% | +$10.6M | 0.12% | 129 |
|
|
2015
Q4 | $227M | Sell |
2,241,397
-3,012,098
| -57% | -$313M | 0.1% | 164 |
|
|
2015
Q3 | $516M | Buy |
5,253,495
+1,368,420
| +35% | +$152M | 0.22% | 65 |
|
|
2015
Q2 | $455M | Sell |
3,885,075
-3,591,355
| -48% | -$392M | 0.19% | 67 |
|
|
2015
Q1 | $734M | Sell |
7,476,430
-609,624
| -8% | -$61.9M | 0.33% | 30 |
|
|
2014
Q4 | $762M | Buy |
8,086,054
+2,108,925
| +35% | +$218M | 0.3% | 33 |
|
|
2014
Q3 | $636M | Sell |
5,977,129
-53,320
| -0.9% | -$5.22M | 0.24% | 52 |
|
|
2014
Q2 | $500M | Buy |
6,030,449
+739,332
| +14% | +$57.5M | 0.22% | 62 |
|
|
2014
Q1 | $375M | Buy |
5,291,117
+3,397,384
| +179% | +$266M | 0.17% | 84 |
|
|
2013
Q4 | $142M | Buy |
1,893,733
+607,295
| +47% | +$42.3M | 0.07% | 242 |
|
|
2013
Q3 | $80.8M | Sell |
1,286,438
-616,633
| -32% | -$36.9M | 0.04% | 383 |
|
|
2013
Q2 | $97.5M | Buy |
+1,903,071
| New | +$99.2M | 0.06% | 277 |
|
Other funds holding GILD
VCM
VPM
Susquehanna International Group's GILD Position: Q1 2026 in Review
Susquehanna International Group increased its Gilead Sciences (GILD) stake by 76% in Q1 2026, buying an estimated $62.5M and bringing the position to 1,032,658 shares worth $144M. The position accounts for 0.02% of the portfolio, ranked #642.
Susquehanna International Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $762M in Q4 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Susquehanna International Group held 1,032,658 shares of Gilead Sciences worth $144M as of Q1 2026.
- Susquehanna International Group bought 446,635 Gilead Sciences shares in Q1 2026, an estimated $62.5M.
- Gilead Sciences made up 0.02% of Susquehanna International Group's portfolio in Q1 2026, its #642 holding.
- Susquehanna International Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Susquehanna International Group's Gilead Sciences position peaked at $762M in Q4 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.